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Objective: Although the products of the HLA subtypes B*2705 and B*2709 differ only in residue 116 
(Asp versus His) within their peptide-binding grooves, they are differentially associated with 
inflammatory rheumatic diseases such as ankylosing spondylitis (AS): B*2705 occurs in AS patients, 
whereas B*2709 is only rarely encountered. The reasons for this distinct association are still unclear 
but could include subtypespecific conformational and dynamic properties of these antigens. The 
present study was undertaken to investigate structural and dynamic differences between B*2705 and 
B*2709 and their possible relationship to subtypespecific disease association. 
Methods: The membrane-distal segments of the B*2705 and B*2709 heavy chains were expressed in 
vitro and reconstituted together with ß2-microglobulin and a peptide. HLA–B27 complexes loaded with 
2 self peptides (TIS [RRLPIFSRL] and pVIPR [RRKWRRWHL]) and a sequence-related viral peptide 
(pLMP2 [RRRWRRLTV]) were studied by isotope-edited infrared spectroscopy to detect differences in 
their structure and flexibility at physiologic temperature. 
Results: Our analyses revealed the existence of subtype-specific conformational differences between 
the 2 HLA–B27 heavy chains at physiologic temperature, which are undetectable using x-ray 
crystallography. Irrespective of the bound peptide, the heavy chain of the B*2705 complex exhibited 
higher conformational flexibility than the B*2709 heavy chain. 
Conclusion: The present study demonstrates the existence of previously undetected systematic 
conformational and dynamic differences between the heavy chains of the 2 HLA–B27 subtypes. Since 
effector cell recognition of cells expressing HLA antigens is dependent on the dynamic properties of 
the interacting cell surface molecules, this HLA–B27 subtype–specific heavy chain flexibility could 
have a role in the distinct association of HLA–B27 subtypes with spondylarthritides. 
 
 
The HLA class I allele (subtype) HLA–B*2705 is strongly associated with ankylosing spondylitis (AS), 
an inflammatory rheumatic disorder, whereas another HLA–B27 allele, HLA–B*2709, exhibits at most 
a weak association (1–3). The 2 encoded proteins differ only by a micropolymorphism (Asp-116 in 
B*2705 and His-116 in B*2709) (4) within the peptide-binding groove that is formed by each of the 
heavy chains (5,6). Pairwise comparison of the functional, biochemical, and biophysical properties of 
these very closely related subtypes may thus shed light on the mechanisms underlying the differential 
disease association, although a haplotypedependent influence of B27-linked genes also cannot be 
excluded at present (7).  
 
The exchange of residue 116 within the HLA–B27 heavy chain has already been found to alter 
recognition of the subtypes by cytotoxic T lymphocytes (8) and the repertoire of bound peptides (9,10). 
The presentation mode of selected peptides by each of the 2 subtypes is affected as well, as shown 
by x-ray crystallography (11–15). The crystal structures suggest that the differential reactivity of 
cytotoxic T lymphocytes with the 2 HLA–B27 subtypes might be due primarily to the presence of 
  
different conformations of the peptides. Studies of HLA–B27 misfolding (16), heavy chain dimerization 
(17), and HLA–B27/human ß2-microglobulin (ß2m)–transgenic rats (18) have focused exclusively on 
the B*2705 subtype, and it is not known whether comparable experiments with B*2709 would have 
yielded different results. Apart from the identification of a self peptide that binds only to AS-associated 
HLA–B27 subtypes and represents a candidate for molecular mimicry with a Chlamydia trachomatis–
derived peptide (19), a unifying feature that would distinguish B*2705 from 
B*2709 and provide an explanation for the association of HLA–B27 with spondylarthritides has not as 
yet been identified.  
 
Although there may be considerable conformational differences between the peptides displayed, a 
comparison of the x-ray structures of the B*2709 and B*2705 subtypes reveals that the structures of 
their heavy chains, as well as those of the noncovalently associated, invariant light chain of the 
complexes, ß2m, are practically indistinguishable (root mean square deviation 0.2–0.3Å) 
(11,12,15,20). Likewise, spectroscopic analyses have not resolved whether distinct properties of 
the subtypes’ heavy chains could be generalized or were due only to the presence of a particular 
peptide within the binding groove (15,21–24). Although these and other analyses provided more 
thorough understanding of many of the biophysical properties of HLA–B27 molecules, findings of 
structure-based studies have not been able to comprehensively account for the differential 
involvement of HLA–B27 subtypes in the pathogenesis of AS. Since experiments with transgenic rats 
revealed that the B27–ß2m complex can cause spondylarthritis (18,25), further studies of the 
molecule’s biophysical and functional properties are mandatory.  
 
X-ray crystallography can provide only very limited information on protein dynamics, and since 
hydrogen atoms of these molecules (roughly 50% of all atoms) are virtually “invisible” due to 
insufficient resolution of the diffraction data, structural information should be supplemented using 
complementary approaches. Determination of specific absorption of infrared (IR) light by spectroscopy 
is a sensitive way to monitor conformational 
changes within proteins or conformational differences between related proteins (26,27). Data can be 
gained from C=O stretching vibrations of amide carbonyl groups (amide I), N–H bending vibration 
coupled to C–N stretching (amide II), and N–H stretching vibration of the peptide groups (amide A). 
Moreover, the solvent accessibility of the protein backbone can be probed by hydrogen/deuterium 
(H/D) exchange experiments, thus providing additional information on the flexibility and dynamics of 
the molecule (27,28). Therefore, the results obtained are distinct from the largely static picture 
obtained with conventional x-ray crystallography and, additionally, supply information on hydrogen 
atoms within a protein.  
 
Using isotope-edited IR spectroscopic analyses with 13C-labeled ß2m, unlabeled heavy chain, and 3 
peptides, we demonstrated in the present study that the B*2705 and B*2709 subtypes exhibit 
previously undetected systematic differences in conformation and flexibility 
at physiologic temperature. We discuss how differential heavy chain dynamics could influence the 
recognition of cells expressing HLA antigens by effector cells. 
 
 
Materials and Methods 
 
Sample preparation. The peptides TIS (RRLPIFSRL, derived from epidermal growth factor response 
factor 1), pLMP2 (RRRWRRLTV, derived from latent membrane protein 2 of Epstein-Barr virus), and 
pVIPR (RRKWRRWHL, derived from vasoactive intestinal peptide type 1 receptor) were synthesized 
and purified as described previously (11,12,15). The extracellular domains of B*2705 and B*2709 as 
well as 13C-labeled ß2m were expressed separately in Escherichia coli as inclusion bodies (24,29). To 
obtain 13C-labeled ß2m, E coli cells were cultured in minimal medium containing uniformly 13C-
labeled glucose (Cambridge Isotope Laboratories, Andover, MA) as described previously (24).  
 
For complex formation, the proteins were solubilised with urea and refolded by dilution in the presence 
of the peptide (29,30). Following reconstitution, the entire mixture was concentrated using Amicon 
Ultra-15 devices with a 10-kd cutoff (Millipore, Billerica, MA), and the complexes were isolated by size-
exclusion chromatography in 10 mM sodium phosphate buffer (pH 7.5)/150 mM NaCl. For IR 
measurements, the sample solutions were concentrated and exchanged into the corresponding D2O 
buffer using Vivaspin 500 concentrators (Sartorius, Göttingen, Germany) with a membrane cutoff of 10 
kd. The final sample concentrations were between 10 and 20 mg/ml before collection of IR data. 
  
Infrared spectroscopy. The protein solutions were always freshly prepared and placed into 
demountable calcium fluoride IR cells with an optical path length of 50 μm for measurements in D2O 
buffer (26). IR spectra were recorded with an IFS-28B Fourier transform infrared spectrometer (Bruker 
Optics, Ettlingen, Germany) equipped with a DTGS detector and continuously purged with dry air. For 
each sample, 128 interferograms were co-added and Fouriertransformed to yield spectra with a 
nominal resolution of 4 cm-1. The sample temperature was controlled with a thermostated cell jacket. 
Spectra at discrete temperatures were obtained by heating the protein solutions from 15°C to 90°C in 
steps of 2.5°C. Buffer spectra were recorded under identical conditions in a matched second cell of 
slightly reduced path length and subtracted from the spectra of the proteins in the relevant buffer. 
Spectral contributions from residual water vapor, if present, were eliminated using a set of water vapor 
spectra. The final unsmoothed protein spectra were used for further analysis. Band positions were 
determined using Opus software (Bruker). Second derivatives were obtained using the Savitzky-Golay 





Choice of B27–peptide complexes. For the present studies, we selected the soluble, recombinant, 
membrane-extrinsic domains of the B*2705 and B*2709 subtypes complexed with 3 ligands. The 
ligands comprised the self peptides TIS (15) and pVIPR (8,11), as well as the viral peptide pLMP2 
(12). These peptides were chosen because high-resolution x-ray crystallography had revealed that the 
TIS peptide is displayed very similarly by the 2 HLA–B27 subtypes, while the pLMP2 peptide and the 
pVIPR peptide exhibit drastically different conformations (Figure 1). In addition, pVIPR is bound by 
B*2709 in a conventional single conformation, but by B*2705 in an exceptional dual conformation. 
These distinct modes of antigen presentation link the emergence of dissimilar, B27-specific T cell 
repertoires in individuals with the different subtypes to the buried Asp116His polymorphism (8,11,12). 
 
Infrared absorbance spectra of B27–TIS complexes. We initially investigated the IR spectroscopic 
behavior of the B*2709–13C-ß2m–TIS and B*2705–
13C-ß2m–TIS complexes after transfer into D2O 
buffer (Figure 2), because only the TIS peptide is bound by both subtypes in a nearly identical 
conformation (6,15) (Figure 1). The spectra were very similar to those previously determined for 
complexes with pVIPR (24), and revealed a feature at ~1,594 cm-1 due to 13C-labeled ß2m as well as 
several heavy chain–specific band components between 1,620 and 1,700 cm-1. The spectral attributes 
of the 9 residues of the TIS peptide were “buried” under those of the 276 heavy chain residues, 
indicating that practically all spectral changes observed must be regarded as contributions of the 
heavy chain. The remaining IR intensity at ~1,545 cm-1 1 hour after transfer into D2O buffer, together 
with the presence of a band at ~3,286 cm-1, showed that a number of amide N–H groups of the heavy 
chain in the complex are protected from H/D exchange. The band at ~3,286 cm-1 (amide 
A) was the best indicator of residual nonexchanged N–H groups, owing to the lack of other protein 
absorption in the range 3,200–3,400 cm-1.  
 
Analogous studies were also carried out with complexes of each HLA–B27 subtype and pLMP2 
(results not shown), in all cases revealing ß2m- and heavy chain–specific spectral features similar or 
even identical to those observed with complexes with TIS (present 
study) or pVIPR (24). Together with the second derivatives of the spectra (thin traces in Figure 2 
provide examples for the 2 complexes with the TIS peptide), these spectral properties form the basis 
for the comparative analyses described below. 
 
Detection of HLA–B27 subtype–dependent conformational properties. IR difference spectra 
(B*2709–13C-ß2m–peptide spectra minus B*2705–
13C-ß2m– peptide spectra) obtained at different 
temperatures were then used to detect the possible presence of subtype-specific conformational 
features (Figure 3). Positive and negative components in these spectra reflect fine structural 
differences, in whose absence only a flat line is obtained. At 15°C, the spectral characteristics in the 
amide A region (a positive feature at ~3,286 cm-1) and in the amide II/II’ region (a positive band near 
1,550 cm-1 and a corresponding negative band near 1,445 cm-1) demonstrated the presence of fewer 
H/Dexchanged amide groups in the heavy chain of B*2709 compared with the B*2705 subtype. More 
specifically, a positive feature at 1,651 cm-1, along with a negative component at ~1,640 cm-1, 
suggests the presence of more nonexchanged amide groups within the helical regions of the complex 
in B*2709 than in B*2705. Since less H/D exchange is an indicator of a diminished degree of protein 
flexibility and, in turn, a sign of reduced accessibility of (inner) regions of a polypeptide to solvent 
molecules, these IR data demonstrated that the B*2705 heavy chain is more flexible than the B*2709 
  
heavy chain.  
 
The weak difference features around 1,690 and 1,621 cm-1 indicated minor differences in peak 
position of the amide I’ bands, attributable to the ß-sheets of the heavy chain. In contrast, only minor 
positive and negative features due to the ß-sheet band of 13C-labeled ß2m (near 1,590 cm
-1) were 
observed, indicating a very similar degree of H/D exchange of the amide protons of ß2m in complex 
with B*2705 or B*2709.  
 
The IR difference spectroscopic features did not change appreciably between 15°C and 55°C (Figure 
3). In contrast, very pronounced differences were observed at 60–65°C (Figure 3). The positive 
features of the IR difference spectrum at these elevated temperatures can be attributed to helical 
(1,640 cm-1) and antiparallel ß-sheet (1,688 and 1,621 cm-1) heavy chain structures (24), which 
indicate a higher amount of residual secondary structure in the B*2709 complex with the TIS peptide 
than in the B*2705 complex with the TIS peptide. This distinguishing characteristic is a consequence 
of the higher thermostability of the B*2709–TIS complex (15). The secondary structure was, in both 
cases, disrupted upon further temperature increases to >70°C, leveling out all spectral differences 
(lower trace in Figure 3). IR difference spectra were also obtained 
from the complexes of both HLA–B27 subtypes with pLMP2 and pVIPR (results not shown), revealing 
the presence of heavy chain–specific spectral features as well, that were characteristic for a given 
HLA–B27 subtype. Taken together these data demonstrated that the observed spectral differences 
are independent from the sequence or conformation of the TIS, pLMP2, or pVIPR peptides in a given 
complex. 
 
Discrete dissimilarities between the spectral characteristics of the HLA–B27 subtypes. The 
quality of the original IR absorbance spectra allowed us to compute differences between the second 
derivative spectra. This enabled us to visualize fine differences in the position, intensity, and shape of 
band components in more detail than would be obtained by simple comparison of the original spectra. 
 
The low-temperature IR difference spectrum obtained by subtracting the second derivative IR 
spectrum of B*2705–13C-ß2m–TIS from that of B*2709–
13C-ß2m–TIS (Figure 4A) revealed a number of 
positive and negative features between 1,700 cm-1 and 1,610 cm-1, reflecting characteristic structural 
differences between the heavy chains of the 2 HLA–B27 subtypes. Specifically, the negative feature at 
1,650 cm-1 revealed a more intense and/or sharper amide I band component in the spectrum of 
B*2709 compared with that of B*2705, corroborating the conclusions derived from analyses of the 
original spectra (Figure 3), i.e., that there are more nonexchanged amide groups present in the helical 
regions of the B*2709 than the B*2705 complexes. Differences in peak position of the high-frequency 
ß-sheet band components at 1,691–1,693 cm-1, together with the minor spectral differences of the low-
frequency ß-sheet band at ~1,623 cm-1, indicate the presence of fine 
differences in hydrogen-bonding patterns of the ß-sheet structures of the heavy chain in the 2 HLA–
B27 samples at low temperatures. In marked contrast, the hightemperature IR difference spectrum 
was featureless (blue trace in Figure 4A) due to a loss of all conformational and dynamic differences 
between the 2 HLA–B27 heavy chain subtypes at 90°C.  
 
We next investigated whether conformational 
differences between the heavy chains of the B*2709 and B*2705 subtypes could also be found in 
complexes with the pLMP2 peptide. Unlike the TIS peptide, this virusderived ligand is bound by the 2 
HLA–B27 subtypes in very dissimilar conformations (12) (Figure 1). However, the spectra of B*2709–
13C-ß2m–pLMP2 and B*2705–
13C-ß2m–pLMP2 recorded at 15°C 1 hour after transfer into D2O buffer 
revealed difference features almost identical to those found with the 2 B27–TIS complexes (Figures 
4A and B), and these also resembled the corresponding IR spectral features of the pVIPRcomplexed 
B*2709 and B*2705 subtypes (Figure 4C). Moreover, the subtype-dependent spectral differences were 
much more pronounced than the spectral differences between 2 independent preparations of the 
corresponding HLA–B27 complexes. This demonstrates the high quality of the experimental data, as 
shown previously for complexes with the pVIPR peptide (24). 
 
Comparison of IR spectroscopic data with results from x-ray crystallographic analyses. It is 
known that spontaneous structural fluctuations as well as local and global unfolding events can 
influence the exchange of amide protons with solvent deuterons (27,28). Therefore, we next evaluated 
the crystallographic temperature factors (B factors) of the structures (Table 1), which highlight regions 
of different flexibility in the crystalline state (11,12,15).  
 
  
An earlier assessment of the B factors for the different structural units of B*2709–pVIPR and B*2705–
pVIPR had failed to provide a clear-cut explanation for the observed subtle differences in amide proton 
protection between the 2 heavy chains (24). In the case of the pVIPR peptide, this might have been 
due to the different resolutions at which the 2 structures had been solved (Table 1). This explanation, 
however, cannot account for the differences between the HLA–B27 subtypes in complex with the 2 
other peptides observed in the present study. For TIS, very similar average B factors of 31.1Å2 
(B*2709) and 34.7Å2 (B*2705) were found, while clearly distinct values of 10.3Å2 and 19.6Å2, 
respectively, were observed in case of pLMP2, affecting residues at positions 7 and 8, in particular 
(12) (Table 1). The B factors for pLMP2 thus revealed that this peptide is more flexibly bound in 
B*2705 than in B*2709, despite the salt bridge–mediated anchoring of its middle through the pArg-5–





Water molecules within and around proteins are of overwhelming importance in stabilizing their tertiary 
and quarternary structures, and in so doing, are directly responsible for protein function (31). For 
example, such molecules are involved in the structural and functional activation of G protein–coupled 
receptors such as rhodopsin (32), and the water shell around the myoglobin molecule powers and 
controls internal motions such as ligand migration (31). An analysis of conserved water molecules in 
major histocompatibility complex (MHC) class I complexes revealed the presence of 3 water clusters 
in nearly all of the structures (33). Distinct locations of solvent molecules within the binding groove 
of different HLA–B27 subtypes, even when the same peptide is presented, must obviously be initiated 
by water molecules that surround the polymorphic heavy chain residue 116 within the F pocket (for 
detailed images of such water networks, see refs. 14 and 29). Similarly, a polymorphic residue within 
the binding groove influences the shape of water networks in HLA–B44 subtypes (34).  
 
We have previously reasoned that differential peptide flexibility in HLA–B27 subtypes presenting 
pLMP2 is most likely the consequence of a network of solvent molecules within the peptide-binding 
groove that is tighter in B*2709 than in B*2705, where the hydrophobic section of the pArg-5 side 
chain prevents its formation (12) (Figure 1). The water network in the F pocket was also found to be 
denser in the less flexible B*2709–TIS complex than in the B*2705–TIS structure(15), while the dual 
conformation of the pVIPR peptide in the B*2705 subtype precludes direct comparison with B*2709 
(11) (Figure 1). In contrast, the solvent molecule cluster is tighter in the complex of B*2705 with the 
model peptide m9 (GRFAAAIAK) than in B*2709–m9, although an additional water molecule is part of 
the cluster that is found in B*2705 (29). This complex is strikingly more stable than the B*2709–m9 
complex (22,35) and exhibits reduced binding groove flexibility (21,36).  
 
Although peptides with a C-terminal lysine, such as m9, cannot bind to B*2709 under natural 
conditions (9,10), studies with the pLMP2, TIS, and m9 peptides allow one to correlate elevated heavy 
chain flexibility with the presence of a less favorably shaped water network within a peptide-binding 
groove and to link these characteristics to the Asp116His polymorphism. It seems unlikely, however, 
that the degree of differential heavy chain flexibility can be appreciably influenced by the lack 
(bacterially expressed heavy chain) or the presence of the glycosyl moiety on the heavy chain, since 
glycosylation occurs at the nonpolymorphic position Asn-86 (37), at a considerable distance from the 
flexible end of the α1-helix (see below).  
 
IR spectroscopy cannot be used to localize the regions where the 2 heavy chains differ, but molecular 
dynamics simulations of complexes of HLA–B27 subtypes with pVIPR have shown increased flexibility 
of the B*2705 binding groove in comparison with that of B*2709 (24), thus corroborating the global 
isotopeedited IR spectroscopic findings. Specifically, the canonical conformation of pVIPR in the 
B*2705 subtype (Figure 1) induces increased flexibility of both α -helices of the heavy chain in the 
region of amino acid residues 75–80 (end of the α 1-helix) and 137–150 (beginning of the α 2-helix), 
i.e., in the vicinity of and “above” the polymorphic residue 116. These segments of the 2 α-helices are 
always connected by hydrogen bonds to a bound peptide (5): the polymorphic heavy chain residue 77 
(Asp, in the case of B*2705 or B*2709) contacts the peptide C-terminal amino acid, while the 
conserved heavy chain residue Trp-147 binds the penultimate peptide residue (Figure 5).  
 
It therefore seems plausible that the Asp116His exchange and the consequential repositioning of 
water molecules exert an influence, by way of the suspended peptide, on the flexibility of the 2 
opposing helical segments of the binding groove. Since the peptide contacts heavy chain residues 77 
  
and 147 through main chain atoms, the flexibility of the 2 α-helical segments should be independent of 
the sequence of a peptide. This is precisely what the present comparative study with 3 distinct ligands 
demonstrates. The last 2 residues of the peptides used in this study are Arg-Leu (TIS peptide), Thr-Val 
(pLMP2 peptide), and His-Leu (pVIPR peptide) (Figure 1).  
Hydrophobic amino acids such as Leu or Val are the preferred C-terminal anchors of B27-bound 
peptides, but basic amino acids (Arg, Lys) can also occur (10). However, the latter are either absent 
from peptides found in B*2709 (in the case of Lys) or are only very rarely observed in this subtype (in 
the case of Arg). It is not known whether the B*2705 heavy chain would be similarly flexible in bound 
peptides that contain a C-terminal basic residue, but molecular dynamics simulations of the m9 
peptide (see above) suggest that this might not be so (21,36). Therefore, firm anchoring of specific 
residues of a peptide through salt bridges at the C-terminus (29,38) might lead to reduced flexibility of 
the B*2705 heavy chain. On the other hand, the present results demonstrate that the additional 
anchoring of a peptide through a centrally located residue that contacts Asp-116 (12) (Figures 1 and 
5B) does not appear to influence heavy chain flexibility. Thus, the observed differential dynamic 
behavior of the 2 HLA–B27 subtypes at physiologic temperature has to be regarded as an intrinsic 
attribute of the heavy chain of the 2 subtypes, and not as a peptide sequence– or 
conformationinduced characteristic.  
 
Two questions come to mind when one tries to reconcile the findings presented here with known 
properties of HLA–B27 molecules: 1) How could dynamic features of histocompatibility antigens be 
influenced by a deeply buried binding groove polymorphism? and 2) Would these biophysical 
characteristics have to be taken into account when attempting to explain the molecular basis of AS 
pathogenesis?  
 
As discussed above, exchanges at the polymorphic residue 116 are invariably accompanied by 
alterations in the network of water molecules within the peptide-binding groove (6,11–15,20,29). In the 
few studies in which this has been investigated (12,15,21,29,36), tighter packing has been found in the 
less flexible HLA–B27 subtype. Looser water molecule packing, on the other hand, would permit the 
peptide main chain to be more flexible and would also lead to increased dynamics of the 2 α-helices, 
since the last 2 C-terminal peptide residues are connected to the 2 α-helices through highly conserved 
contacts (5,20) (Figure 5). 
Heavy chain dynamics are thus dependent not only on the polymorphic residue 116 and the distinct 
water cluster that surrounds its side chain, but also on the presence of a peptide. However, heavy 
chain flexibility is at the same time independent from the sequence and conformation of the bound 
peptide (Figure 4), establishing heavy chain dynamics as a novel characteristic that distinguishes 
B*2705 and B*2709. Since the function of a protein is inescapably connected to its dynamics (31,39), 
altered conformational plasticity of class I MHC complexes will influence their interaction with ligands. 
 
Therefore, and particularly with regard to the relevance of these findings for AS pathogenesis, the 
most plausible assumption may be that the flexibility of the α-helices exerts an effect on the interaction 
with T cell receptors (TCRs) and killer cell immunoglobulinlike receptors (KIRs) on effector cells 
(40,41). Causal involvement of CD8+ cytotoxic T lymphocytes in spondylarthritides in B*2705/human 
ß2m-transgenic rats has recently been excluded (42). Although the situation in humans could 
obviously be different, these results do suggest that models of AS pathogenesis in which CD8+T cells 
do not likely play a decisive role should be considered. Since KIR molecules on natural killer (NK) cells 
interact with those regions of HLA–C antigens that exhibit homology with flexible α-helical segments 
on B*2705–peptide complexes (24,41), we will briefly consider the possible consequences of our 
findings with regard to NK cell reactivity.  
HLA class I–KIR interfaces exhibit striking charge complementarity. The interaction is characterized by 
a high energy threshold for recognition (41) and 
in many ways resembles the observed interaction between the CD2 and CD58 cell surface antigens 
(43). HLA and KIR molecules typically behave as rigid bodies, quite unlike the situation in HLA–TCR 
interactions in which, in particular, the TCR loops can be very flexible (40). Therefore, elevated 
dynamics of the HLA molecule, as seen in the B*2705 subtype presenting peptides with aliphatic C-
termini, could result in impaired recognition of the complex by inhibitory KIRs (KIR3DL1 in the case of 
HLA–B27 molecules). In turn, this might lead to activation of NK cells, and possibly even lysis of the 
target cell. KIR molecules that recognize HLA–B27 antigens not only are numerous, but are also 
polymorphic, and their combined actions on cells expressing HLA–B27 molecules are insufficiently 
understood (ref. 44; for review, see ref. 45). Nevertheless, it is reasonable to assume that KIRs might 
play a role in AS pathogenesis, and our finding of differential flexibility between 2 HLA–B27 subtypes 
in a region of the binding groove that is recognized by these receptors offers the opportunity to relate 
  
their activity to a subtype-intrinsic, peptide sequence– and conformation-independent heavy chain 
property that is a consequence of micropolymorphism at heavy chain position 116.  
 
Finally, it should be kept in mind that dynamic characteristics of the binding groove also likely play a 
role in the process of loading the molecule with a suitable peptide within the endoplasmic reticulum 
(46–48). Notably, B*2705 and other AS-associated subtypes fold much more slowly than subtypes that 
are not associated with AS (e.g., B*2709) (46), and this is also observed when complexes with the 
heavy chain of various subtypes are reconstituted in vitro (Huser H, Uchanska-Ziegler B: unpublished 
observations). It is not known whether these differences can be regarded as a consequence of distinct 
heavy chain flexibility, but in the absence of another explanation, this possibility should at least be 
considered.  
 
In conclusion, although the findings of the present study do not explain the involvement of HLA–B27 
antigens in AS pathogenesis, they provide a picture of these molecules that goes beyond the purely 
static view derived from conventional x-ray crystallographic analyses. Nuclear magnetic resonance 
spectroscopic analyses of HLA–B27 subtypes that are differentially associated with AS might 
eventually enable investigators to merge the structural and dynamic features of these subtypes and 
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Tables and Figures 
 
 




* Average temperature factor (B factor) for all peptide residues.  
† References cited are those in which the crystal structure of the given B27–peptide complex has 






Conformations of the peptides TIS (left), pLMP2 (middle), and pVIPR (right) within the peptide-binding 
groove of the B*2709 and B*2705 subtypes. The peptide conformations are shown in complex with 
B*2709 (top) and B*2705 (bottom). Only the TIS peptide is displayed very similarly by both subtypes, 
while the middle part of pLMP2 is bound in drastically different conformations due to the formation of a 
salt bridge between pArg-5 of this peptide and Asp-116 of the heavy chain, which is possible only in 
B*2705. In addition, while TIS (15) and pLMP2 (12) are bound by both B27 subtypes in a single 
conformation, for pVIPR this is observed only in the case of B*2709 (11). In contrast, the binding of 
this peptide by B*2705 occurs in a unique dual conformation with roughly equal occupancy. While one 
of the binding modes resembles that found in B*2709 (yellow), the other (orange) is distinct from the 
first between pLys-3 and pTrp-7. It is characterized by the formation of a salt bridge between pArg-5 







Infrared (IR) absorbance spectra B*2709 and B*2705, each complexed with 13C-ß2-microglobulin and 
TIS. B*2705, 13C-ß2m, and TIS. B*2709–
13C-ß2m–TIS and B*2705–
13C-ß2m–TIS were measured 
at 15°C (thick lines), 60°C (dashed lines), and 90°C (dotted lines), 1 hour after transfer into D2O buffer. 
The IR spectra in the amide I region (C=O stretching vibration of the peptide bond) are characterized 
by a maximum corresponding to the heavy chain (1,640 cm-1) and a pronounced shoulder at ~1,594 
cm-1, which indicates the presence of ß-sheet structure of 13C-labeled ß2m in the complex. The weak 
feature at ~1,545 cm-1 is due primarily to the amide II band (N–H bending vibration strongly coupled to 
C–N stretching) of nonexchanged amide backbone groups of the heavy chain. Exchange of protons 
with deuterons is accompanied by a decrease of the band intensity at ~1,545 cm-1 and an increase of 
band intensity at ~1,445 cm-1 (amide II’). Residual nonexchanged N–H groups are directly indicated by 
a positive band at ~3,286 cm-1 (amide A). The thin traces represent the second derivatives of the 
spectra for each of the complexes at 15°C. The 6 negative peaks between 1,620 cm-1 and 1,700 cm-1 





















IR difference spectra between B*2709–13C-ß2m–TIS and B*2705–
13C-ß2m–TIS. Difference spectra 
were obtained by subtracting the absorbance spectrum of B*2705–13C-ß2m–TIS from that of B*2709–
13C-ß2m–TIS at the indicated temperatures. The first spectrum of each sample (at 15°C) was obtained 
1 hour after transfer into D2O buffer. The spectra of the 2 samples were normalized using the 
intensity of the tyrosine band at 1,514 cm-1 as an internal standard. The component at ~1,550 cm-1 
and a corresponding negative feature at ~1,445 cm-1, together with a positive band at ~3,286 cm-1, 
indicate a slightly lower degree of hydrogen/deuterium exchange of the amide groups of the B*2709 
heavy chain compared with the B*2705 heavy chain at low temperatures. Note that the ordinate of the 
difference spectra has been expanded by a factor of 10 compared with the ordinate of the absorbance 




































Peptide-independence of increased heavy chain flexibility of B*2705 complexes. The second 
derivative IR spectra of the TIScomplexed (A), pLMP2-complexed (B), and pVIPR-complexed (C) 
B*2709–13C-ß2m and B*2705–
13C-ß2m (black and red lines in part a in each panel, respectively), at a 
temperature of 15°C, 1 hour after transfer into D2O buffer, are shown. (Data in C are from previous 
work by our group [24].) Part b in each panel depicts the IR difference spectra (B*2709 minus B*2705) 
of the second derivatives at 15°C (orange traces) and at 90°C (blue traces). The low-temperature IR 
difference spectra provide evidence of a very close similarity of the structure and flexibility between the 
2 complexes with the 3 peptides. The high-temperature IR difference spectra are flat, demonstrating 
the loss of all differences between the HLA–B27 subtypes that were apparent at low temperatures. 
Part c in A and B depicts the IR difference spectra of the second derivatives of experiments with 2 
independent preparations of each HLA–B27–peptide complex (continuous traces represent HLA–
B*2709; dashed traces represent HLA– B*2705) at 15°C, demonstrating the high reproducibility of the 



















Conserved interactions between a displayed peptide and α-helices of the peptide-binding groove. The 
interactions of the peptide residues p8 (main chain carbonyl) and Trp-147 (side chain NE atom) and of 
p9 (main chain amide) and Asp-77 (side chain OD1 atom) in the TIS (A), pLMP2 (B), and pVIPR (C) 
peptides are depicted. The structures of B*2709 and B*2705 are superimposed; oxygen atoms are 
shown in red and nitrogen atoms in blue. The view is from a slightly ”elevated“ position near the 
carboxy-terminal amino acid, roughly parallel to the peptide main chain. Only the peptide segments 
from p5 to p9 are shown, and side chains are omitted with the exception of pIle-5 (TIS) and pArg-5 
(pLMP2 and pVIPR). The latter residue points in different directions in the 2 subtypes (shown in the 
same color [blue] for pLMP2) or within the B*2705 subtype (noncanonical peptide conformation shown 
in orange for pVIPR). Hydrogen bonds (peptide–α-helix interactions) and salt bridges (pArg-5–Asp-
116 interactions) are depicted as dotted lines. Differences in peptide sequences and conformations 
still permit the formation of highly conserved hydrogen bonds between the α-helices (α1 and α2) and 
peptide main chain atoms in all 6 structures. 
 
 
  
